
Clear only while on treatment? That’s controlled, not in remission. #IPCCouncilor Dr. José-Manuel Carrascosa on BeNeBio: at 18 months, 73% stayed on reduced IL-17/IL-23 inhibitor doses. Flares: 15.9% vs 6.3%. Would you extend intervals? psoriasiscouncil.org/comment…
























